Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04928157 · ClinicalTrials.gov registry record · Phase 2
Prospective Randomized Trial of CPAP for SDB in Patients Who Use Opioids
A Phase 2 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 2
- Development phase
- 62
- Enrollment target
NCT04928157 is a Phase 2 study that has completed, run by University of California, San Diego. The registered enrollment target is 62 participants.
The verdict
NCT04928157, a Phase 2 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 62 participants
- Enrollment target
Study Summary
Patients with chronic pain who use opioids appear to be at increased risk for breathing issues during sleep, termed sleep disordered breathing (SDB). Treatment of SDB often consists of use of a device during sleep that provides continuous positive airway pressure (CPAP) via a mask interface. The goal of this study is to determine whether patients with chronic pain who use opioids and have SDB might benefit from the use of CPAP in terms of sleep quality, pain, quality of life, and other measures. In addition, the study will examine whether these individuals are able to adhere to CPAP, which will be important for future studies. Lastly, we anticipate that CPAP won't work for everyone due to the changes that opioids can cause in breathing patterns. We will examine how often CPAP is ineffective, and whether we can predict which individuals are least likely to resolve their SDB with CPAP.
Interventions
- DEVICE Positive Airway Pressure (PAP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2021-08-10 |
| Est. Completion | 2024-09-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04928157
The ClinicalTrials.gov registry entry for NCT04928157 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Positive Airway Pressure (PAP) is the first listed.
NCT04928157 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04928157 about?
NCT04928157 is a clinical study titled "Prospective Randomized Trial of CPAP for SDB in Patients Who Use Opioids". Patients with chronic pain who use opioids appear to be at increased risk for breathing issues during sleep, termed sleep disordered breathing (SDB). Treatment of SDB often consists of use of a device during sleep that provides continuous positive airway pressure (CPAP) via a mask interface. The goa...
What is the current status of trial NCT04928157?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 62 participants. The study started on 2021-08-10. Estimated completion is 2024-09-12.
What interventions are being tested in trial NCT04928157?
The interventions under investigation include: Positive Airway Pressure (PAP) (DEVICE).
Who is sponsoring clinical trial NCT04928157?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.